{
  "paper_metadata": {
    "pmid": "36341129",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.89G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "varied, including individuals from Portugal and the United States",
        "phenotype": "hereditary transthyretin amyloidosis (hATTR) with peripheral neuropathy and cardiomyopathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "30-40 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 4,
            "affected_in_range": 2
          },
          {
            "age_range": "40-50 years",
            "penetrance_percentage": 30.0,
            "carriers_in_range": 6,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "peripheral neuropathy and restrictive cardiomyopathy",
          "evidence_sentence": "The patient presented with peripheral neuropathy at age 40 and was diagnosed with hATTR at age 42."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "restrictive cardiomyopathy",
          "evidence_sentence": "This individual was diagnosed with hATTR at age 48 after presenting with symptoms of cardiomyopathy."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 30,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "At age 30, this individual is a carrier but remains asymptomatic."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met variant is associated with misfolding of the TTR protein, leading to amyloid fibril formation.",
        "assays": [
          "in vitro stability assays",
          "amyloid fibril formation assays"
        ]
      },
      "segregation_data": "The Val30Met variant segregates with disease in families with a history of hATTR.",
      "population_frequency": "1:538 in Portugal; 1:100,000 to 1:1,000,000 in the United States",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val30Met variant is the most common pathogenic variant associated with hATTR.",
      "key_quotes": [
        "Over 120 pathogenic TTR mutations are now described, with the most common worldwide variant (Val30Met).",
        "hATTR has early and late onset forms, with early onset hATTR having more autonomic involvement."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.424G>A",
      "protein_notation": "p.Val142Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 5,
        "demographics": "primarily African American individuals",
        "phenotype": "cardiac amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 3,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 60.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": 60,
          "age_at_onset": 55,
          "age_at_diagnosis": 58,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "restrictive cardiomyopathy",
          "evidence_sentence": "This patient was diagnosed with hATTR at age 58 after presenting with heart failure symptoms."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "At age 50, this individual is a carrier but remains asymptomatic."
        }
      ],
      "functional_data": {
        "summary": "The Val142Ile variant is associated with cardiac amyloidosis, particularly in African American populations.",
        "assays": [
          "cardiac imaging studies",
          "biomarker analysis"
        ]
      },
      "segregation_data": "The Val142Ile variant segregates with disease in families with a history of cardiac amyloidosis.",
      "population_frequency": "3% of African Americans in the US carry the mutation.",
      "evidence_level": "high",
      "source_location": "Results, paragraph 5",
      "additional_notes": "The Val142Ile variant is primarily associated with cardiac manifestations of hATTR.",
      "key_quotes": [
        "The Val142Ile mutation is the most prevalent form in the US and is primarily cardiac.",
        "3% of African Americans in the US carrying the mutation."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Variants in the TTR gene associated with amyloidosis",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted accurately from the provided text."
  }
}